Hepatitis

FDA Approves Sovaldi For Hepatitis C

Gilead Sciences' Sovaldi (sofosbuvir) received approval from the U.S. Food and Drug Administration for the treatment of hepatitis C.

Hospital Tech Who Infected Patients With Hepatitis C Faces Up To 40 Years In Federal Prison

David Kwiatkowski, a traveling hospital technician who infected at least 32 people with hepatitis C using syringes tainted with his own infected blood, will receive his sentence on Monday.

OxyElite Pro Recall 2013: Hepatitis, Liver Failure Cited In HHS Probe

All OxyElite Pro weight loss supplements are being recalled and destroyed, the FDA said in a press release.

Gilead Combination Pill Cures 95% Hepatitis C Patients

A double-drug combination pill was able to cure 95 percent of hepatitis C patients, regardless of how they responded to currently available treatments.

Pregnancy Could Help Hepatitis C Develop Into Hardier Strain

In one mother, the processes that occurred during pregnancy combined with the natural viral processes of hepatitis C to help create a strain that was able to replicate faster.

Las Vegas Doctor, Dipak Desai, Sentenced To Life In Prison After Hepatitis C Scandal

The doctor who infected nine patients with Hepatitis C is guilty of 27 charges and has received a life sentence.

New Syringe Remembers If It Has Been Used By Someone Else

The ABC syringe could prevent 700,000 blood-borne infections and save $130 million in medical costs, developers say.

Hepatitis A Scare In NYC: City Providing Free Vaccinations

Chopped fruit at New York City's Westside Market may have been contaminated with hepatitis A, according to health officials.

Hepatitis C Sexually Transmitted between HIV-infected Men

Centers for Disease Control and Prevention (CDC), provides substantial evidence that men with HIV who have sex with other men (MSM) are at increased risk for contracting HCV through sex.

Analysis finds mortality from all causes higher among hepatitis C-infected

Although liver-related mortality among those infected with hepatitis C is well-documented, little is known about deaths in these patients that are not related to liver problems.

Coffee drinking improves hepatitis C treatment response

Advanced hepatitis C patients with chronic liver disease may benefit from drinking coffee during treatment, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute. Patients who received peginterferon plus ribavirin treatment and who drank three or more cups of coffee per day were two times more likely to respond to treatment than non-drinkers.